← SynDRA
SR-146131
SynDRA canonical compound SYN1966509 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | CCKAR |
|---|
| Mechanism of action | cck receptor agonist |
|---|
| Indication | neuroblastoma |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- cck receptor agonist
- CCKAR AGONIST
Cross-references
Synonyms
- SR 146131
- SR146131
- NFDFTMICKVDYLQ-UHFFFAOYSA-N
- GTPL868
- SCHEMBL1008694
- DTXSID5047370
- CHEMBL3302616
- NCGC00247967-01
- HY-11077
- CS-0003037
- L000574
- 2-(4- (4-Chloro-2,5-dimethoxyphenyl)-5-cyclohexylethyl-2-thiazolylcarbamoyl)-5,7-dimethyl-1-indoleacetic acid
- 2-[2-[[4-(4-chloro-2,5-dimethoxyphenyl)-5-(2-cyclohexylethyl)-1,3-thiazol-2-yl]carbamoyl]-5,7-dimethylindol-1-yl]acetic acid
Look up SR-146131 in the interactive SynDRA portal →